How tech is accelerating diagnoses and treatments
How tech is accelerating diagnoses and treatments
The last year has seen a global rise in chronic health conditions such as diabetes and a significant increase in wearable medical technology and wireless in-home healthcare, as companies focus on how to diagnose and treat patients faster and more accurately.
While large medtech companies with products focused on COVID diagnostics have been forced into significant layoffs as their COVID testing businesses have dropped from their pandemic peaks, many small to mid-size organisations have seen continued growth as they seek regulatory approval and commercialisation for Class II and III devices.
What’s the outlook for medtech talent in 2024?
Which technologies will be most important in diagnosis and treatment? And which skills will be top of hiring companies’ wish lists as medical technology continues to advance?
Read the report
To find out more on the key areas medical device and diagnostics leaders need to prepare for in 2024, check out our medical device and diagnostics market snapshot in UNLOCKED: Talent Insights 2024.
Learn more
BioTalent is part of The IN Group, a collective of six specialist talent brands. Learn more about The IN Group here.
NPS Score
70+ is considered world-class
76
Get in touch
Whether you're hiring or job hunting, we're here to make the process simple. Reach out and let's talk.
All Rights Reserved 2026 BioTalent
